| 1 |
Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio frequency thermal ablation versus percutaneous ethanol injection. Radiology, 2003,228(1):235-240.
|
| 2 |
Rossi S, Di Stasi M, Buscarini E. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol, 1996,167(3):759-768.
|
| 3 |
Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma—An analysis of 1000 cases. Cancer, 2005,103(6):1201-1209.
|
| 4 |
陈敏山, 张耀军, 李锦清, 等. 射频消融治疗肝脏恶性肿瘤的八年经验总结(附803例报道）. 中华外科杂志, 2007,45(21):1469-1471.
|
| 5 |
Livraghi T, Solbiati L, Meloni MF, et al. Treatment of liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiofrequency, 2003,226(2):441-451.
|
| 6 |
梁惠宏,陈敏山,王旭东, 等. 经皮射频消融治疗不同类型肝癌的疗效分析. 中华肝脏病杂志, 2004,12(12):756-757.
|
| 7 |
Vivarelli M, Guglielmi A, Ruzzenete A，et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann. Surg, 2004, 240(1):102-107.
|
| 8 |
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg, 2006,243(3):321-328.
|
| 9 |
Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology, 2008,47(1):82-89.
|
| 10 |
Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Radiofrequency ablationversus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg, 2008,12(1):192-198.
|
| 11 |
Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg, 2009,249(1):20-25.
|
| 12 |
Bruix J, Sherman M. AASLD Practice Guideline: Management of hepatocellular carcinoma: an update (2010). J Hepatol, 2010,53(3):1020-1022.
|
| 13 |
中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组. 2009年原发性肝癌规范化诊治的专家共识. 临床肿瘤学杂志, 2009,14(3):259-269.
|
| 14 |
中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组. 原发性肝癌局部消融治疗的专家共识. 临床肿瘤学杂志, 2011,16(1):70-73.
|
| 15 |
Liang HH, Chen MS, Peng ZW, et al. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol, 2008,15(12):3484-3493.
|
| 16 |
Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology, 2007,244(2):599-607.
|
| 17 |
Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med, 2008,359(4):378-390.
|
| 18 |
Ma HQ, Zhang YJ, Wang QJ, et al. Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation. Cancer Biol Ther, 2010,9(4):1-5.
|